Last Seen Blogs
tongsyu
Tongsyu
crearemagazinonline
CREARE magazin
nicklovesbbws
BOOTY APPRECIATION PAGE
yungartschool
Artschool
allergic-to-reality
Allergic-to-Reality
Text
Healthcare Information Systems Market to expand at a CAGR of 7.1% by 2019
Persistence Market Research Released New Market Report on “Global Market Study on Healthcare Information Systems: Asia to Witness Highest Growth by 2019” the global healthcare information systems market was valued at USD 35.2 billion in 2013 and is expected to grow at a CAGR of 7.1% from 2013 to 2019, to reach an estimated value of USD 53.2 billion in 2019. Aging population and rising healthcare costs globally are playing a major role in increasing the demand for healthcare information systems. As a result, the market for healthcare information systems is expected to grow at a CAGR of about 7.1% during 2013 – 2019.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/2886
Some of the key driving factors for the healthcare information systems market are raising government initiatives, rising need for integrated healthcare systems and increasing investment from healthcare IT players. However, the market faces some restraints such as lack of experienced professionals, high maintenance and service expenses and interoperability issues.
Healthcare information systems market is also witnessing shift from manual process to computerized process. Introduction of wireless and cloud technology, patient-centric healthcare information systems and use of mobile devices are some of the major trends that have been observed in the market. Also, trends such as adoption of electronic health record and geographic expansion by some leading players have been observed in the global market for healthcare information systems. North America dominates the global healthcare information system market followed by Europe.
Asia is expected to experience high growth rate, due to the increasing demand of healthcare information systems in emerging markets such as China and India. Increase in aging population, increase in incidence rate of various chronic diseases such as diabetes, chronic pain are acting as the driving factors for healthcare information systems market in these regions. On the basis of application, laboratory information system has the largest market for healthcare information systems. This segment is expected to grow at a CAGR of about 7.7% during 2013 – 2019.
Healthcare information systems market is also segmented on the basis of delivery mode; web based cloud based and on-premise; by components: software, hardware and services; by geographies: North America, Europe, Asia Pacific and Rest of the World (RoW).
Request for Report Methodology @: https://www.persistencemarketresearch.com/methodology/2886
Some of the companies operating in healthcare information systems market are GE Healthcare, Philips Healthcare, McKesson Corporation and Nextgen Healthcare Information System Inc.. GE Healthcare is one of the leading players in healthcare information systems market.
0 notes
Text
Uk Private Healthcare Market to Reach a Valuation of US$ 14,000 Mn By 2025
The decline in individual purchases of private medical insurance and low medical cover pay-outs to clinics and hospitals will continue to negatively impact the U.K. private healthcare market. Besides, the country has a well-defined public healthcare structure for its permanent residents. At the point of need, public healthcare coverage is subsidized or offered completely free and is usually paid through general taxation. Persistence Market Research in its latest study reveals that the U.K. private healthcare market is set to expand at a sluggish 2.8% CAGR during the forecast period (2017–2025). In addition, this market is anticipated to represents an absolute $ opportunity of US$ 321.4 Mn in 2018 over 2017. According to PMR findings, the U.K’s private healthcare sector is much smaller than the public sector. However, a rise in self-pay elective procedures and introduction of attractive packaged pricing is expected to support the country’s private healthcare sector in the near future.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/16030
PMR’s report titled “Private Healthcare Market: U.K. Industry Analysis, 2012 – 2016 and Forecast, 2017 – 2025” further identifies some of the key trends governing the U.K.’s private healthcare market under the influence of multiple factors. Leading private healthcare providers in the country are now offering several fixed packages for various procedures and treatments in an attempt to lure more patients. The focus has shifted toward a more meticulous marketing of medical services to patients. Some of the private companies are using local media and medical scheme membership brochures to reach out to more number of people. Market players are also investing in improving out-patient services, setting up day clinics and sub-acute beds in order to increase their services offerings.
Hospital of St. John’s & St. Elizabeth, Care UK, CIRCLE HOLDINGS PLC, BMI Healthcare, Nuffield Health, HCA Management Services, L.P., Ramsay Health Care, Spire Healthcare Group plc., The London Clinic, Aspen Healthcare (A Sub. Of Tenet Healthcare), Bupa Cromwell Hospital, The Huntercombe Group, KIMS Hospital, 3fivetwo Group, London Welbeck Hospital, The Bournemouth Private Clinic Limited, Alliance Medical, King Edward VII's Hospital, The Private Clinic, and Vein Centre Limited are the key players operating in the region’s private healthcare market. Currently, Ramsay holds the top position in the market, maintaining around 21.1% share despite the growing competition.
As per the report, increasing waiting times for various treatment and procedures at public healthcare centers is prompting patients to opt for private healthcare services. This, in turn, is expected to create lucrative market opportunities for private healthcare organizations during the forecast period.
Request for Report Methodology @: https://www.persistencemarketresearch.com/methodology/16030
Additional Excerpts of the Report Include:
The demand for private acute care services, private specialist services, and private patient care services is projected to remain higher as compared to other private healthcare services over 2025. By 2017-end, private hospitals that provide acute care services are expected to account for more than 57% value share of the market.
Based on end-users, self-pay individuals and NHS referrals are expected to collectively account for a massive market share in terms of revenue. Over the next couple of years, increasing out-of-pocket spending on healthcare expenses is projected to create further demand for private healthcare services in the country.
0 notes
Link
Persistence Market Research in its latest study reveals that the U.K. private healthcare market is set to expand at a sluggish 2.8% CAGR during the forecast period (2017–2025). In addition, this market is anticipated to represents an absolute $ opportunity of US$ 321.4 Mn in 2018 over 2017. Read more at: https://www.persistencemarketresearch.com/market-research/uk-private-healthcare-market.asp
0 notes
Link
Persistence Market Research Released New Market Report on “Global Market Study on Healthcare Information Systems: Asia to Witness Highest Growth by 2019” the global healthcare information systems market was valued at USD 35.2 billion in 2013 and is expected to grow at a CAGR of 7.1% from 2013 to 2019, to reach an estimated value of USD 53.2 billion in 2019. Read more at: https://www.persistencemarketresearch.com/market-research/healthcare-information-systems-market.asp
0 notes
Text
Neuroscience Market Projected to Reach US$ 520 Mn by 2025
With healthy CAGR of 6.4%, the global neuroscience market is likely to grow from US$ 301.6 Mn in 2016 to US$ 520.8 Mn by 2025 end. This growth is mainly fuelled by advancement in neuroimaging and increasing R & D in neuroinformatics. “Neuroscience Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” is the new publication of Persistence Market Research that focuses on merger and acquisition, strategic collaborations and technology, and technology transfer agreements, which play a vital role in the global neuroscience market. North America and Europe are expected to dominate the global neuroscience market in the assessed period of 8-years that is between 2017 and 2025.
Global Neuroscience Market: Relevance and Impact of Factors
Increasing consumer awareness regarding neuroscience and easy accessibility of the technology
Growing acceptance of e-health and integrated medical system
Increasing strategic collaborations among key players
Rise in incidence rate of lifestyle diseases and geriatric population worldwide
Reforming healthcare IT spending structure and advancement in digital technology
Shift towards value-based healthcare model
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/13390
Global Neuroscience Market: Forecast by Component Type
On the basis of component type, the global neuroscience market is segmented into instrument, software and services. Instrument segmented is sub-segmented into MRI imaging systems and neuromicroscopy, while services segmented divided into consulting services, installation services and maintenance services. Instrument segment dominated the global neuroscience market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. Instrument segment is the most attractive segment, with attractiveness index of 2.6 over the forecast period. Instrument segment was valued at US$ 221.6 Mn in 2016 and is projected to be valued at US$ 408.1 Mn in 2025 growing at a CAGR of 7.2% during the forecast period. This segment is expected to accounts for high revenue contribution to the global neuroscience market as compared to software and services segments over the forecast period.
Software segment is expected to be the second most lucrative segment in the global neuroscience market, with attractiveness index of 0.3 during the forecast period. This segment was accounted for 15.4% value share in 2017 which is expected to drop down to 12.9 % revenue share in 2025.
Global Neuroscience Market: Forecast by End User
On the basis of end user, global neuroscience market is segmented into hospitals, diagnostic laboratories, research institutes, and academic institutes. Diagnostics laboratory segment is expected to be the second most lucrative segment in the global neuroscience market by 2025 end. However, in terms of CAGR and revenue share, hospitals segment is expected to lead he market throughout the estimated period. In 2025, hospital segment is likely to grab 40.2% market share in 2025, expanding at a robust CAGR of 7.3% during the estimated period. Research institutes segment is expected to be the least attractive segment in the global neuroscience market, with attractiveness index of 0.7 during the forecast period.
Global Neuroscience Market: Forecast by Region
On the basis of region, global neuroscience market is segmented into North America, Latin America, Europe, APAC and MEA. North America dominated the global neuroscience market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. North America is projected to be the most attractive market with attractiveness index of 2.3 during the forecast period. Europe is expected to be the second most lucrative market, with attractiveness index of 1.1 respectively during the forecast period. Europe Neuroscience market accounted for 23.9% share in 2017 and is projected to account for 23.1% share by 2025 end.
Request for Report Methodology @: https://www.persistencemarketresearch.com/methodology/13390
Global Neuroscience Market: Key Players
Carl ZEISS AG, Danaher Corporation (Leica Microsystems), GE Company, Siemens AG, Koninklijke Philips N.V., Toshiba Corporation, Hitachi Medical Corp., Esaote SpA, HAAG-STREIT Group, Opto fine Instruments Pvt. Ltd., Synaptive Medical, Operating Microscopes and Pridex Medicare Pvt. Ltd. are some of the key players operating in the global neuroscience market.
0 notes
Text
Precision Medicine Market to Grow at a CAGR of 14% through 2024
The latest report published by Persistence Market Research titled “Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024". projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.
Global Precision Medicine Market: The Propellers
The global expansion of the medicine industry will expand the canvas of the global precision market. Larger investments, better infrastructure, simplified approval process of drugs along with companion diagnostics will impact the structure of the entire climate of the global precision medicine market. The affordable DNA profiling, the bloating cancer population of the globe will create a favorable condition of growth for the global precision medicine market. The proper storage of genome data plays a crucial part in this segment. The emergence of data backed medicare will also drive the global precision market ahead.
But the market is combating acute data storage and data privacy issues and it also lacks in systematic approach towards funding and soaring prices of personalized drugs is also creating a blockade in the expansion of the global precision medicine market.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/12646
Global Precision Medicine Market: Market Autopsy
The global precision medicine market is bifurcated into multiple parent segments which are further sub-categorized. The primary division of the market is an assimilation of three, region, technology and application. The major technologies which will define the market character in the forthcoming years are bioinformatics, next-gen sequencing and drug discovery technology. The applications segment will showcase fruitful results and oncology will act as the showstopper. The market prediction shows that this segment will bloom and will touch an approximate value of US$ 69 Bn by the end of the assessment period. The approximate registered CAGR of this segment within the assessed period will be above 13.5%. The global population is struggling with some of the acute diseases such as arthritis. A large slice of the aged population is an easy prey of this crippling ailment. The immunology segment will reap maximum benefits from the population affected by arthritis. The immunology segment will gain revenue from the market and the market worth will cross US$ 34 Mn by the end of 2024.
Global Precision Medicine Market: Regional Scrutiny
The regional market arena has penetrated through different key regions of the globe. The global precision medicine market has extended its boundaries in the last few years. The product has a massive global presence and it is expanding steadily. Apart from North America, Europe, MEA, Latin America and Asia Pacific regions are other major pockets which are expected to show fruitful outcome in the forthcoming years. The global precision medicine market is expected to perform well in the North American region and it will occupy more than 35% of the market share within the period of prediction. The global precision market in North America will flourish and will probably touch the approximate market value of more than US$ 60 Mn by 2024 end. With a stupendous performance the US and Canada will conquer a lion share of the global precision medicine market of this region predicts the report. The Europe is a consistent market and will crawl up the revenue chart within the forecast period. The global precision market in Europe will ride an estimated CAGR of more than 13% to sew up an average worth of more than US$ 40 Mn by the end of 2024. In Europe the markets spread across Germany and France will shape the destiny of this market. Apart from this the countries such as Spain, UK and Italy will also follow the leading pack during the period of assessment. The APAC region is the rising star of the global precision medicine market. The region will project a CAGR of more than 14% during the period of projection. The market will witness a staggering hike and will touch approximately US$ 35 Mn by the end of 2024. In the APAC region Japan will spearhead the market, China and India will lock horns to accumulate maximum market share during the projected period. The region of Latin America will score considerable revenue during this period. MEA will be a sulking market as less of research activities will dampen the spirit of the precision medicine market.
Request for Report Methodology @: https://www.persistencemarketresearch.com/methodology/12646
Global Precision Medicine Market: Comparative Landscape
The market is evolving fast with the better and bigger market tie-ups. The bonhomie between IT and healthcare is also expediting the market and providing a bigger playground to the stakeholders. Novartis AG, Laboratory Corporation of America Holdings, Eli Lilly And Company, AstraZeneca are contributing massively in the overall development of the global precision medicine market.
0 notes
Link
Global confocal microscope market is projected to reach US$ 1,310.5 Mn by the end of 2028 and grow at a CAGR of 3.3% during the forecast period. Get access to full summary @: https://www.persistencemarketresearch.com/market-research/confocal-microscope-market.asp
0 notes
Link
According to a study conducted by Persistence Market Research (PMR), the global market for cryotherapy is set to witness a CAGR of 6.5% during the forecast period 2016-2024. Cryotherapy Market to Surpass US$ 4 Billion by the end of 2024. Get access to full summary @: https://www.persistencemarketresearch.com/market-research/cryotherapy-market.asp
0 notes
Link
Global neuroscience market is expected to grow from more than US$ 300 Mn in 2016 to more than US$ 520 Mn by 2025 end. This represents a CAGR of 6.4% over the forecast period of 2017–2025. Get access to full summary @: https://www.persistencemarketresearch.com/market-research/neuroscience-market.asp
#Neuroscience Market#Neuroscience Market Size#Neuroscience Market Growth#Neuroscience Market Forecats
0 notes
Link
The global precision medicine market, estimated to be worth around US$ 56 Bn by 2016 end, is expected to expand at an approximate CAGR of 14% over the forecast period of 2016–2024. North America accounted for largest market share and the net average net worth of the market was close to US$ 19 Bn in 2015 and is expected to expand at a CAGR of more than 13.5 % over the forecast period. Get access to full summary @: https://www.persistencemarketresearch.com/market-research/precision-medicine-market.asp
0 notes
Link
Global orthopedic trauma devices market is apprehended to attain the revenues in excess of US$ 14 Bn by the end of 2028. Over a 10 year forecast period, the global market for orthopedic trauma devices will possibly expand at a promising CAGR of 6.8%, as per the research. Get access to full summary @: https://www.futuremarketinsights.com/reports/orthopedic-trauma-devices-market
0 notes
Link
According to the report, the global varicella zoster infection treatment market is expected to register a 4.2% CAGR from 2017 to 2027. In 2016, the market was worth US$ 1,257.1 Mn and is expected to reach a valuation of US$ 1,969.1 Mn by the end of 2027. Get access to full summary @: https://www.futuremarketinsights.com/reports/varicella-zoster-infection-treatment-market
0 notes
Link
The global 3D printed medical devices market is expected to expand at a CAGR of 18.1% during the forecast period 2017–2027. Get access to full summary @: https://www.futuremarketinsights.com/reports/3d-Printed-medical-devices-market
0 notes
Link
According to the research report, the global market for exosome diagnostic and therapeutics is expected to grow at a high CAGR to reach an estimate of over US$ 150 Mn by the end of the year of assessment from a value of about US$ 19 Mn in 2017. Get access to full summary @: https://www.futuremarketinsights.com/reports/exosome-diagnostic-and-therapeutics-market
0 notes
Link
According to this research report the global healthcare regulatory affairs outsourcing market is expected to reach a market revenue of over US$ 2,000 Mn by the end of 2025, growing at a stellar CAGR of 12.2% over the forecast period. Get access to full summary @: https://www.futuremarketinsights.com/reports/healthcare-regulatory-affairs-outsourcing-market
0 notes
Link
In terms of revenue, the global pneumococcal vaccines market is projected to expand at 9.1% CAGR over the forecast period of 2018–2028. The pneumococcal vaccines market is expected to be valued at US$ 18,456.5 Mn by 2028 end. Read more at: https://www.futuremarketinsights.com/reports/pneumococcal-vaccines-market
0 notes
Link
In terms of value, the global veterinary molecular diagnostics market is estimated to expand from a value of US$ 126.5 Mn in 2017, to a value of US$ 242.6 Mn by 2026 end at a CAGR of 7.6% during the forecast period. Read more information at: https://www.futuremarketinsights.com/reports/veterinary-molecular-diagnostics-market
0 notes